Device
Sirolimus Drug Coated Balloon
Sirolimus Drug Coated Balloon is a medical device with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
unknown133%
recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
recruitingnot_applicable
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
NCT06271590
recruitingnot_applicable
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
NCT05908331
unknown
A Real-world Registry Investigating Sirolimus-coated Balloon Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Dysfunctional Arteriovenous Fistula
NCT05333640
Clinical Trials (3)
Showing 3 of 3 trials
NCT06271590Not Applicable
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
NCT05908331Not Applicable
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
NCT05333640
A Real-world Registry Investigating Sirolimus-coated Balloon Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Dysfunctional Arteriovenous Fistula
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3